Patient/ Caregiver Survey

Thank you to everyone who took the time to complete the survey. The response was fantastic!

Myeloma Summit 2018 Queenstown

Thanks to everyone who attended the Queenstown summit.
The latest Multiple Myeloma Research Review - Issue 27

Latest News

You’re invited to a patient seminar – Auckland

INVITATION Patient Seminar: Minimal residual disease in Myeloma  with Prof. Nikhil C. Munshi on Sunday 31 March, from 4 – 5pm at North Shore Hospital Auditorium – Whenua Pupuke,...
Continue Reading

Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma

Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial....
Continue Reading

Going the distance: Are we losing patients along the multiple myeloma treatment pathway?

Despite data suggesting that individuals with multiple myeloma can benefit from receiving several lines of therapy, and guidelines recommending treatment...
Continue Reading

Single-cell Profiling in Multiple Myeloma May Improve Diagnosis, Treatment, Study Suggests

Analysis of thousands of individual cells in multiple myeloma patients allows for a much more precise diagnosis — distinguishing asymptomatic, early-stage patients...
Continue Reading

Lenalidomide Maintenance Therapy for Multiple Myeloma

Orally administered lenalidomide, a second-generation antimyeloma thalidomide analog, is a workhorse in contemporary management of multiple myeloma: it is approved by...
Continue Reading

Myeloma Study Makes the Case for a New Standard for Predicting Long-Term Outcome

As new treatments for multiple myeloma have extended patient survival—from an average of three years to more than 10 in some cases—physicians...
Continue Reading


Every quarter we’ll post news and information in our myeloma newsletter. If you would like to join the community of patients and caregivers receiving this subscribe below.